165 related articles for article (PubMed ID: 33753181)
1. LMP2A suppresses the role of AHR pathway through ERK signal pathway in EBV-associated gastric cancer.
Jiang Y; Xiao H; Sun L; Zhang Y; Liu S; Luo B
Virus Res; 2021 May; 297():198399. PubMed ID: 33753181
[TBL] [Abstract][Full Text] [Related]
2. LMP2A inhibits the expression of KLF5 through the mTORC1 pathway in EBV-associated gastric carcinoma.
Liu D; Shi D; Xu L; Sun L; Liu S; Luo B
Virus Res; 2022 Jul; 315():198792. PubMed ID: 35500764
[TBL] [Abstract][Full Text] [Related]
3. EBV down-regulates COX-2 expression via TRAF2 and ERK signal pathway in EBV-associated gastric cancer.
Qi YF; Liu M; Zhang Y; Liu W; Xiao H; Luo B
Virus Res; 2019 Oct; 272():197735. PubMed ID: 31473273
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 induces cell autophagy and maintains EBV latent infection in EBVaGC.
Wang W; Zhang Y; Liu W; Zhang X; Xiao H; Zhao M; Luo B
Theranostics; 2020; 10(25):11549-11561. PubMed ID: 33052232
[No Abstract] [Full Text] [Related]
5. Maintenance of Epstein-Barr virus latency through interaction of LMP2A with CXCR4.
Qin N; Zhang Y; Xu L; Liu W; Luo B
Arch Virol; 2022 Oct; 167(10):1947-1959. PubMed ID: 35752684
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
[TBL] [Abstract][Full Text] [Related]
7. Latent membrane protein 2A inhibits expression level of Smad2 through regulating miR-155-5p in EBV-associated gastric cancer cell lines.
Shi Q; Zhang Y; Liu W; Xiao H; Qi Y; Li J; Luo B
J Med Virol; 2020 Jan; 92(1):96-106. PubMed ID: 31469179
[TBL] [Abstract][Full Text] [Related]
8. Nuclear respiratory factor 1 promotes the progression of EBV-associated gastric cancer and maintains EBV latent infection.
Liang Y; Liu W; Zhao M; Shi D; Zhang Y; Luo B
Virus Genes; 2023 Apr; 59(2):204-214. PubMed ID: 36738378
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of gastric carcinoma cell clones expressing LMP2A of Epstein-Barr virus.
Seo JS; Jun SM; Kwon SW; Oh IH; Kim TG; Lee SK
Int J Mol Med; 2010 Jan; 25(1):11-6. PubMed ID: 19956896
[TBL] [Abstract][Full Text] [Related]
10. Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Han J; Chen JN; Zhang ZG; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(3):e34276. PubMed ID: 22470549
[TBL] [Abstract][Full Text] [Related]
11. LMP2A induces DNA methylation and expression repression of AQP3 in EBV-associated gastric carcinoma.
Wang J; Liu W; Zhang X; Zhang Y; Xiao H; Luo B
Virology; 2019 Aug; 534():87-95. PubMed ID: 31220652
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome sequencing of LMP2A-transfected gastric cancer cells identifies potential biomarkers in EBV-associated gastric cancer.
Liu W; Xiao H; Song H; An S; Luo B
Virus Genes; 2022 Dec; 58(6):515-526. PubMed ID: 35819701
[TBL] [Abstract][Full Text] [Related]
13. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
[TBL] [Abstract][Full Text] [Related]
14. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase.
Chen SY; Lu J; Shih YC; Tsai CH
J Virol; 2002 Sep; 76(18):9556-61. PubMed ID: 12186939
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R; Barse L; Stone A; Vagvala S; Montesano M; Subramaniam V; Swanson-Mungerson M
Virology; 2017 Jan; 500():96-102. PubMed ID: 27792904
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]